(Q44215275)

30 November 2017

title

Inhibition of progesterone-induced VEGF production in human breast cancer cells by the pure antiestrogen ICI 182,780. (English)

1 reference

30 November 2017

Salman M Hyder

1

1 reference

30 November 2017

George M Stancel

series ordinal

2

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

181

1 reference

30 November 2017

issue

1

1 reference

30 November 2017

page(s)

47-53

1 reference

Tamoxifen, raloxifene, and the prevention of breast cancer

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900048-4

7 January 2021

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900048-4

7 January 2021

American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900048-4

7 January 2021

Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900048-4

7 January 2021

ICI 182,780 (Faslodex): development of a novel, "pure" antiestrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900048-4

7 January 2021

Angiogenesis in cancer, vascular, rheumatoid and other disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900048-4

7 January 2021

Angiogenesis and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900048-4

7 January 2021

Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900048-4

7 January 2021

Prognostic value of vascular endothelial growth factor in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900048-4

7 January 2021

Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900048-4

7 January 2021

Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900048-4

7 January 2021

High-performance hydrophobic interaction chromatography of estrogen receptors and magnesium dependent protein kinase(s): detection of two molecular forms of estrogen receptors in the presence and absence of sodium molybdate

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900048-4

7 January 2021

Ligand-Modulated Regulation of Progesterone Receptor Messenger Ribonucleic Acid and Protein in Human Breast Cancer Cell Lines

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900048-4

7 January 2021

Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900048-4

7 January 2021

Treatment of breast cancer with different antiprogestins: preclinical and clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900048-4

7 January 2021

Vascular endothelial growth factor (VEGF) in human breast cancer: Correlation with disease-free survival

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900048-4

7 January 2021

10.1016/S0304-3835(02)00048-4

Identifiers

DOI

1 reference

30 November 2017

1 reference